Glioblastoma is one of the most aggressive solid tumors, and, despite treatment options such as surgery, radiation, and chemotherapy, its prognosis remains grim. Novel approaches are needed to improve survival. Immunotherapy has proven efficacy for melanoma, lung cancer, and kidney cancer and is now a focus for glioblastoma. In this article, glioblastoma-mediated immunosuppression will be discussed and two exciting immune approaches, checkpoint inhibitors and viral-based therapies, will be reviewed.
Description
Current State of Immune-Based Therapies for Glioblastoma. - PubMed - NCBI
%0 Journal Article
%1 Lim:2016:Am-Soc-Clin-Oncol-Educ-Book:27249715
%A Lim, M
%A Weller, M
%A Chiocca, E A
%D 2016
%J Am Soc Clin Oncol Educ Book
%K cancer fulltext glioblastoma immunotherapy therapy
%P 132-139
%R 10.14694/EDBK_159084
%T Current State of Immune-Based Therapies for Glioblastoma
%U https://www.ncbi.nlm.nih.gov/pubmed/27249715
%V 35
%X Glioblastoma is one of the most aggressive solid tumors, and, despite treatment options such as surgery, radiation, and chemotherapy, its prognosis remains grim. Novel approaches are needed to improve survival. Immunotherapy has proven efficacy for melanoma, lung cancer, and kidney cancer and is now a focus for glioblastoma. In this article, glioblastoma-mediated immunosuppression will be discussed and two exciting immune approaches, checkpoint inhibitors and viral-based therapies, will be reviewed.
@article{Lim:2016:Am-Soc-Clin-Oncol-Educ-Book:27249715,
abstract = {Glioblastoma is one of the most aggressive solid tumors, and, despite treatment options such as surgery, radiation, and chemotherapy, its prognosis remains grim. Novel approaches are needed to improve survival. Immunotherapy has proven efficacy for melanoma, lung cancer, and kidney cancer and is now a focus for glioblastoma. In this article, glioblastoma-mediated immunosuppression will be discussed and two exciting immune approaches, checkpoint inhibitors and viral-based therapies, will be reviewed.},
added-at = {2017-04-17T17:38:48.000+0200},
author = {Lim, M and Weller, M and Chiocca, E A},
biburl = {https://www.bibsonomy.org/bibtex/2c4042c3276bf572071ec7347583808d7/marcsaric},
description = {Current State of Immune-Based Therapies for Glioblastoma. - PubMed - NCBI},
doi = {10.14694/EDBK_159084},
interhash = {cd878a446fade207e0313009252e7633},
intrahash = {c4042c3276bf572071ec7347583808d7},
journal = {Am Soc Clin Oncol Educ Book},
keywords = {cancer fulltext glioblastoma immunotherapy therapy},
pages = {132-139},
pmid = {27249715},
timestamp = {2017-10-07T23:14:36.000+0200},
title = {Current State of Immune-Based Therapies for Glioblastoma},
url = {https://www.ncbi.nlm.nih.gov/pubmed/27249715},
volume = 35,
year = 2016
}